Kamal, M.; Navai, N.; Bree, K.K.; Williams, L.A.; Cleeland, C.S.; Shen, S.-E.; Wang, X.S.
Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting. Cancers 2022, 14, 3896.
https://doi.org/10.3390/cancers14163896
AMA Style
Kamal M, Navai N, Bree KK, Williams LA, Cleeland CS, Shen S-E, Wang XS.
Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting. Cancers. 2022; 14(16):3896.
https://doi.org/10.3390/cancers14163896
Chicago/Turabian Style
Kamal, Mona, Neema Navai, Kelly K. Bree, Loretta A. Williams, Charles S. Cleeland, Shu-En Shen, and Xin Shelley Wang.
2022. "Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting" Cancers 14, no. 16: 3896.
https://doi.org/10.3390/cancers14163896
APA Style
Kamal, M., Navai, N., Bree, K. K., Williams, L. A., Cleeland, C. S., Shen, S. -E., & Wang, X. S.
(2022). Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting. Cancers, 14(16), 3896.
https://doi.org/10.3390/cancers14163896
